X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
female (11) 11
male (11) 11
aged (10) 10
middle aged (10) 10
oncology (10) 10
index medicus (9) 9
adult (7) 7
colorectal cancer (5) 5
medicine & public health (5) 5
research (5) 5
aged, 80 and over (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
endocrinology & metabolism (4) 4
fluorouracil - administration & dosage (4) 4
mellitus (4) 4
surgery (4) 4
7-36 amide (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
cancer (3) 3
cancer therapies (3) 3
capecitabine (3) 3
chemotherapy (3) 3
diabetes mellitus, type 2 - metabolism (3) 3
further section · weitere sektionen (3) 3
gastroenterology & hepatology (3) 3
glucose (3) 3
hematology, oncology and palliative medicine (3) 3
leucovorin (3) 3
neoplasm staging (3) 3
paper (3) 3
risk (3) 3
treatment outcome (3) 3
type 2 diabetes (3) 3
1st-line treatment (2) 2
adenocarcinoma (2) 2
adenocarcinoma - drug therapy (2) 2
adenocarcinoma - pathology (2) 2
anthracyclines (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
c-peptide - blood (2) 2
care and treatment (2) 2
chemoradiation (2) 2
chemoradiotherapy (2) 2
chemotherapy, adjuvant (2) 2
cisplatin - administration & dosage (2) 2
clinical trials (2) 2
colorectal neoplasms - drug therapy (2) 2
diabetes (2) 2
disease-free survival (2) 2
enzyme-linked immunosorbent assay (2) 2
esophageal (2) 2
esophageal cancer (2) 2
fluorouracil - therapeutic use (2) 2
follow-up (2) 2
further section (2) 2
gastric-inhibitory polypeptide (2) 2
glucagon-like peptide 1 (2) 2
hematology (2) 2
ii trial (2) 2
iii trial (2) 2
infusion (2) 2
insulin (2) 2
insulin - blood (2) 2
insulin - metabolism (2) 2
insulin secretion (2) 2
leucovorin - administration & dosage (2) 2
medical informatics (2) 2
medical prognosis (2) 2
medicine, general & internal (2) 2
metastases (2) 2
metastasis (2) 2
mrc cr07 (2) 2
multicenter (2) 2
oncology, experimental (2) 2
open-label (2) 2
organoplatinum compounds - administration & dosage (2) 2
oxaliplatin (2) 2
pancreas (2) 2
product development (2) 2
proportional hazards models (2) 2
radiotherapy (2) 2
rectal neoplasms - therapy (2) 2
reference values (2) 2
review article (2) 2
secretion (2) 2
stomach cancer (2) 2
stomach neoplasms - drug therapy (2) 2
stomach neoplasms - pathology (2) 2
surveillance (2) 2
survival (2) 2
tumors (2) 2
abdominal surgery (1) 1
abridged index medicus (1) 1
acquired resistance (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - secondary (1) 1
adenocarcinoma - surgery (1) 1
adenocarcinoma - therapy (1) 1
adenoma - blood (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 12, pp. 1697 - 1708
Journal Article
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1948 - 1957
Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma. This study reports on the safety and efficacy... 
SURGERY | REGRESSION | MEDICINE, GENERAL & INTERNAL | MULTICENTER | RESECTION | CHEMORADIOTHERAPY | OPEN-LABEL | ESOPHAGEAL | CANCER | STOMACH | Capecitabine - administration & dosage | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Oxaliplatin - therapeutic use | Stomach Neoplasms - pathology | Cisplatin - administration & dosage | Fluorouracil - therapeutic use | Docetaxel - administration & dosage | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Oxaliplatin - administration & dosage | Administration, Oral | Esophagogastric Junction - pathology | Treatment Outcome | Capecitabine - therapeutic use | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Digestive System Surgical Procedures | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Docetaxel - therapeutic use | Aged | Neoplasm Staging | Adenocarcinoma | Anthracyclines | Chemotherapy | Leucovorin | Product development | Esophageal cancer | Cancer | Intravenous administration | Control methods | Toxicity | Clinical trials | Oncology | Metastasis | Cancer therapies | Stomach cancer | Metastases | Confidence intervals | Infusion | Oxaliplatin | Motivation | Surgery | Intravenous infusion | Epirubicin | Medical research | Survival | Patients | Cisplatin | Esophagus | Interactive systems | Medical prognosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 979 - 989
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 7, pp. 679 - 687
Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 1/2019, Volume 64, Issue 1, pp. 204 - 212
Crohn’s disease (CD) leads to bowel damage and surgery in a significant proportion of patients.The aim of the study was to evaluate the predictive value of... 
Biochemistry, general | Bowel damage | Medicine & Public Health | Small bowel MRI | Hepatology | Gastroenterology | Oncology | Creeping fat | Prediction of outcome | Transplant Surgery
Journal Article
DEUTSCHES ARZTEBLATT INTERNATIONAL, ISSN 1866-0452, 01/2013, Volume 110, Issue 3, pp. 32 - U28
Journal Article
Hepatology, ISSN 0270-9139, 04/2009, Volume 49, Issue 4, pp. 1257 - 1266
Hepatic cirrhosis is a life‐threatening disease arising from different chronic liver disorders. One major cause for hepatic cirrhosis is chronic hepatitis C.... 
PROTEIN | PEGINTERFERON ALPHA-2B | CHRONIC HEPATITIS-C | SAMPLING VARIABILITY | STELLATE CELLS | MARKERS | RANDOMIZED-TRIAL